952
Participants
Start Date
June 13, 2022
Primary Completion Date
December 27, 2023
Study Completion Date
April 23, 2024
THS use
N/A: No intervention was assigned.
Cigarette smoking
N/A: No intervention was assigned.
Smoking abstinence
N/A: No intervention was assigned.
Klinische Forschung Dresden GmbH, Sachsen
Medical Centre Asklepii, Kyustendil
Velocity Clinical Research Leipzig, Leipzig
Medical Centre Leo Clinic EOOD, Lovech
Medical Center Zara-Med EOOD, Stara Zagora
Medical Center ReSpiro, Razgrad
Velocity Clinical Research Germany GmbH, Berlin
Praglandia s.r.o., Prague
Klinische Forschung Hamburg GmbH, Hamburg
Schaum/Hecht_RED Institut fur medizinische Forschung und Fortbildung GmbH, Oldenburg in Holstein
Klinische Forschung Hannover-Mitte GmbH, Hanover
Ordinance praktickeho lekai'e, Přeštice
Aristotle University Thessaloniki/Papageorgiou Hospital, Thessaloniki
Synexus Clinical Research GmbH, Frankfurt
Klinische Forschung Karlsruhe GmbH, Karlsruhe
PreventaMed s.r.o., Olomouc
Samoncho Clinic, Tokyo
Yokohama Minoru Clinic, Kanagawa
OPHAC Hospital, Osaka
OCROM Clinic, Osaka
Private Internal ambulance, Karlovy Vary
Clintrial s.r.o., Prague
Vestra Clinics s.r.o., Rychnov nad Kněžnou
emovis GmbH, Berlin
Centrum für Diagnostik und Gesundheit, Klinische Forschung und Entwicklung, München
Praxis Reinfeld Mitte, Reinfeld
National and Kapodistrian University of Athens, Medical school, Attikon Hospital, 2nd Cardiology Department, Athens
Hakata Clinic, Fukuoka
Nishikumamoto Hospital, Minami
Sumida Hospital, Tokyo
Zdravi - fit, s.r.o., Protivín
ToCROM Clinic, Tokyo
Centrum Medyczne Pratia, Katowice
Clinical Medical Research Sp. z o.o., Katowice
Tomed Tomasz Miszalski-Jamka, Krakow
Synexus Polska Sp zoo OddziaL w Lodzi, Lodz
Bioresearch Group, Nadarzyn
Philip Morris Products S.A.
INDUSTRY